Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin
Crossref DOI link: https://doi.org/10.1038/tpj.2016.52
Published Online: 2016-07-26
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Spracklen, T F
Vorster, A A
Ramma, L
Dalvie, S
Ramesar, R S
Text and Data Mining valid from 2016-07-26
Version of Record valid from 2016-07-26
Article History
Received: 25 February 2016
Revised: 6 May 2016
Accepted: 18 May 2016
First Online: 26 July 2016
Competing interests
: The authors declare no conflict of interest.